Citations of Sino Biological Products and Services

Up to 15th, May, there are 69 publications that have cited SARS-CoV-2 reagents or services providing by Sino Biological Inc. Here we list part of those publications.

• Wang, C et al.A human monoclonal antibody blocking SARS-CoV-2 infection. Nature Communications.2020
• Ou, X, et al.Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications.2020
• Renhong Yan, et al.Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science.2020
• Linlin Bao, et al.The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice.Nature.2020
• Lamers, MM, et al.SARS-CoV-2 productively infects human gut enterocytes. Science.2020
• Rockx, B, et al.Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science.2020
• Long, QX, et al.Antibody responses to SARS-CoV-2 in patients with COVID-19. Nature Medicine.2020
• Ni, L, et al.Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity.2020
• Huibin Lv, et al.Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Reports.2020
• Yunlong Cao, et al.Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells.Cell.2020
• Dora Pinto, et al.Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.Nature.2020

There are almost 210 citations which were published in Cell, Nature, Science and their sub-journals and other high impact factor journals.

Note: All these logos are downlaod from their website.